United Therapeutics Corp.

( )
UTHR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
MDCOMedicines Company
VRXValeant Pharmaceuticals International, Inc.
AMRNAmarin Corporation Plc Sponsored ADR
PRGOPerrigo Co. Plc
JAZZJazz Pharmaceuticals Plc
GWPHGW Pharmaceuticals PLC Sponsored ADR
SAGESAGE Therapeutics, Inc.
CTLTCatalent Inc
MNKMallinckrodt Plc
ENDPEndo International Plc
UTHRUnited Therapeutics Corporation
PTLAPortola Pharmaceuticals, Inc.
ICPTIntercept Pharmaceuticals, Inc.
AERIAerie Pharmaceuticals, Inc.

Company Profile

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.